JP3284762B2 - Health management system - Google Patents

Description

DETAILED DESCRIPTION OF THE INVENTION

[0001]

BACKGROUND OF THE INVENTION The present invention estimates the risk of cancer specific to women (uterine, breast, and ovarian cancer), and realizes the risk of developing cancer in daily life. It is related to a health management system that promotes improvement in health and screening, and prevents women-specific cancer.

[0002]

2. Description of the Related Art As a conventional home health care system, there is a system in which a urine analyzer is installed and glucose, protein, urobilinogen, occult blood and the like are measured at home (for example, US Pat. No. 4,962,550; 5-228
116, JP-A-5-49603). However, they are important for early detection and health management of adult diseases such as diabetes, liver function and kidney disease, but they are not effective for prevention of cancer specific to women and health care.

[0003] As a method for routinely detecting hormones and judging the state of the body, there is a method for judging pregnancy by detecting human chorionic gonadotropin (Japanese Unexamined Patent Publication (Kokai) No. Heisei 2).
No.-107965). However, these methods also have no means for estimating the risk of developing cancer by detecting female hormones. Except for the determination of pregnancy, the detection of hormones is left to medical institutions, and there is no system in medical institutions that estimates the risk of developing cancer from the above causal relationship.

[0004]

[Problems to be solved by the present invention]
Women with breast cancer, uterine cancer, etc. who are over 30 years old are also encouraged by local governments to undergo annual cancer screening. Breast cancer is increasing with the increase in animal fat intake, and uterine cancer is still on the top of women's cancer although it is on a decreasing trend, and primary prevention of cancer specific to women is desired. However, other than screening as secondary prevention, there is no technology for estimating the risk of developing cancer in daily life as primary prevention, and it is cumbersome and practically difficult to continue to pay attention to diet and daily life in a healthy state. there were.

[0005] In addition, female hormones mainly include follicular hormone and progesterone, and the secretion amount varies depending on the ovarian cycle. Therefore, when grasping the change in the amount of hormone, it was necessary to always consider the influence of the ovarian cycle depending on the detection time.

[0006] The present invention is to solve the above problems,
By estimating the risk of developing cancer from the relationship between female hormones and steroid hormones at a given time during the ovarian cycle in women, the effects of changes in the amount of hormone secreted by the ovarian cycle are eliminated, making it suitable for hormone detection under the same conditions each time. Provide a health management device that promotes health management by detecting hormones at the time of secretion and effectively estimating the risk of developing cancer and making the user aware of the risk of developing cancer in daily life That is the primary purpose.

[0007]

A second object of the present invention is to provide a health management system which is easy to use in daily life by automatically detecting female hormones and steroid hormones from urine.

[0009]

In order to achieve the above object, a health care system according to the present invention comprises a female hormone detecting means for detecting female hormones, a steroid hormone detecting means for detecting steroid hormones, and a female hormone detecting means. A hormonal signal storing means for storing the output signal of the steroid hormone detecting means in time series; an ovarian cycle calculating means for calculating an ovarian cycle from a change in the amount of female hormone stored in the hormone signal storing means; A risk-of-cancer-risk-estimation calculating means for estimating and calculating the risk of developing a female-specific cancer from the amounts of female hormones and steroid hormones at predetermined times in And a display means for displaying the stored contents of the cancer incidence risk rate storage means. Only to those that you configured.

[0010]

In order to achieve the second object, the health care system according to the present invention provides a hormone detection system which can be detected from urine excreted in daily life so that a user does not need to pay special attention for the detection of hormones. It is configured by providing means.

[0012]

According to the health management system of the present invention, female hormones and steroid hormones are detected by the above configuration, the ovarian cycle is first detected from changes in female hormones, and the relative difference between female hormones and steroid hormones at a predetermined time within the ovarian cycle. In addition, since the risk of cancer onset of a woman is estimated from the balance and the balance, the user can grasp the risk of cancer onset for each predetermined ovarian cycle. In addition, since measurement is performed at a predetermined time within the ovarian cycle, the effects of changes in the amount of female hormone secreted during the ovarian cycle can be eliminated, and hormones can be detected under conditions suitable for hormone detection. The rate can be estimated. Further, an estimated value of the risk of developing cancer is displayed for each predetermined ovarian cycle, and the user can be aware of the risk of developing cancer almost at regular intervals, so that there is no need to pay attention to the examination time.

[0013]

Secondly, since the hormone detecting means of the health care system of the present invention automatically detects hormones from urine when urinating, it is not necessary to carry out each test even at home, and operability is improved. I do.

[0015]

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS An embodiment of the present invention will be described below with reference to FIG.

FIG. 1 is a block diagram of a health management system according to an embodiment of the present invention. Reference numeral 1 denotes a toilet seat device attached to a toilet bowl 2, which includes a washing unit for washing a human body, a drying unit, and a toilet seat heating unit. It has means and the like (not shown). Reference numeral 3 denotes a hormone detecting unit, which is composed of a female hormone detecting means 5 for detecting a female hormone from the signal of the urine sensor 4 and a steroid hormone detecting means 6 for detecting a steroid hormone from the signal of the urine sensor 4, and is linked to the urinating action. Work. Reference numeral 7 denotes an arithmetic circuit, which is a hormonal signal storage means 8 for storing the hormonal signals from the hormonal detector 3 in time series, and the ovarian cycle based on the time series change of the female hormone signal stored in the hormonal signal storage means 8 for a predetermined period. Ovarian cycle calculating means 9 for calculating the hormonal signal storage means 8, female hormones and steroid hormones after a predetermined date from the ovulation period in the ovarian cycle grasped by the ovarian cycle calculating means 9 And a cancer onset risk rate estimating means 10 for estimating the cancer onset risk rate from the value of, and a cancer onset risk rate storing means 11 for storing an output result of the cancer onset risk rate estimating means 10. Numeral 12 denotes personal information input means for inputting information which is said to be related to the onset of cancer, such as the age of the user, childbirth experience, and eating habits. From cancer information and female and steroid hormone levels. Reference numeral 13 denotes an operation display unit having a display screen, which is configured to display the storage contents of the cancer incidence risk rate storage unit 11 and operate the washing unit, the drying unit, the toilet seat heating unit, and the health management system on the display screen. Have been.

Next, the operation and operation of this embodiment will be described. When the user sits on the toilet seat device 1, a personal identification screen of the user is displayed on the display screen of the operation display means 13, and the user performs the personal identification of the user by selectively operating the display screen. When the user urinates, the urine sensor 4 automatically operates to perform urine analysis. The female hormone detecting means 5 detects female hormone from the signal of the urine sensor 4, and the detected female hormone is stored in the hormone signal storage means 8. On the other hand, the steroid hormone detecting means 6 detects steroid hormone from the signal of the urine sensor 4 and is stored in the hormone signal storage means 8. The ovarian cycle calculating means 9 calculates the ovarian cycle from the time-series change of the female hormone stored in the hormone signal storage means 8 and determines at which time of the ovarian cycle the detection date falls.

There are two types of female hormones, estrogen and progestin, and their secretion varies depending on the ovarian cycle. FIG.
Fig. 1 shows changes in secretion levels of estrogen and progestin during the ovarian cycle. Estrogen rapidly increases before the ovulation period, and upon ovulation, progestin is secreted. If pregnancy is not established, estrogen and luteal hormone decrease with regression of the luteum, leading to the onset of menstruation. Therefore, when estimating the risk of cancer on the basis of the secretion tendency of female hormones and steroid hormones, the influence of the ovarian cycle may be large. It is about one week after ovulation that both the levels of estrogen and progesterone are secreted moderately in the ovarian cycle, so that if they are detected at this time, the hormone amount can be easily calculated. Therefore, when the detection date corresponds to a predetermined date from the time of the ovulation cycle within the ovulation cycle, that is, about one week after ovulation, the cancer incidence risk rate estimation calculating means 10 receives the signal from the ovarian cycle calculating means 9. The values of the female hormone and the steroid hormone stored in the hormone signal storage means 8 are relatively compared with each other, and the female hormone and the steroid hormone are compared with the respective standard predetermined amounts, and the comparison calculated value in the predetermined period is calculated. A risk-of-cancer-risk estimation calculation is performed based on the change in the change rate. Female hormones mainly include estrogen and progesterone. Among the hormones detected in urine, breast cancer patients have high steroid hormones and low progestin hormone, and uterine cancer patients have high estrogen and low steroids. In addition, ovarian cancer patients tend to have low levels of both female and steroid hormones.

That is, the calculation result of the risk-of-cancer-risk estimation calculating means 10 shows that the risk of developing breast cancer is high when the steroid hormone is high for a predetermined period and the internal lutein hormone of the female hormone is low, and that the internal hormone estrogen is high for the female hormone. When steroid hormones are low, the risk of uterine cancer increases, and when both female hormones and steroid hormones are low, the risk of ovarian cancer increases.

In recent years, the increase in breast cancer has been remarkable, and uterine cancer has been on a decreasing trend, but is still a high cause of death. It is said that the intake of high amounts of animal fats in the diet increases the incidence of breast cancer, and that women with a high birth experience have cervical cancer and women with a low birth experience have a high incidence of endometrial cancer. Various factors, such as diet, stress, and childbirth experience, affect the hormonal environment and are associated with cancer development in women. Accordingly, the personal information such as age, childbirth experience, and dietary habits input to the personal information input means 12 are input to the cancer risk assessment and calculation means 10 together with the output signals of the female hormone detection means 5 and the steroid hormone detection means 6. An estimation operation is performed.

Estimation means 1 for estimating the risk rate of developing cancer
The output result of 0 is displayed on the display screen of the operation display means 13, and the user can grasp the estimated cancer risk rate. Therefore, the user can promote health management by being aware of the risk of developing cancer every time on a predetermined date from the ovulation period to improve daily life.

As described above, in the present embodiment, the urine sensor 4 is provided on the toilet seat device 1 attached to the toilet bowl 2, and the female hormone detecting means 5 and the steroid hormone detecting means 6 are determined by the signals of the urine sensor 4. Since the detection is performed, the user can detect hormones from urine during daily urination, and can easily detect hormones in daily life without performing complicated operations.

In addition, the risk of cancer onset is estimated and calculated from the values of female hormones and steroid hormones after a predetermined date from the ovulation period in the ovarian cycle calculated by the ovarian cycle calculating means 9. Because the hormone status at a certain time is compared, the effects of changes in secretion amount due to the ovarian cycle are eliminated, and by detecting the hormone at the optimal secretion time for the comparison calculation, the risk of cancer development can be effectively increased. An estimation operation can be performed.

Further, a personal information input means 12 can be provided to input personal information which is said to be related to the onset of cancer, such as the age of the user, childbirth experience, and eating habits. Since the risk of cancer risk estimation is calculated from the signal from the personal information input means 12 and the values of the female hormone and steroid hormone stored in the hormone signal storage means 8, the risk of cancer risk can be estimated more effectively. Will be possible.

[0025]

As described above, the health care system of the present invention is provided with a cancer risk estimation calculation means for estimating a cancer risk specific to a woman. It is possible to continuously understand the danger of cancer and realize the necessity of improving life, thereby promoting the primary prevention of cancer, for which health management in daily life is considered important.

Further, the health management system of the present invention is provided with ovarian cycle calculating means for calculating the ovarian cycle from the output result of the female hormone detecting means. The cancer onset risk is estimated and calculated from the values of female hormones and steroid hormones after a predetermined date from the inner ovulation period of the ovarian cycle determined by the calculating means. As a result, the risk of cancer development can be estimated from the hormonal state at a certain time in the ovarian cycle every time. By detecting the hormone at the appropriate time, it is possible to perform an effective cancer risk assessment calculation.

[0027]

Further, the health management system of the present invention automatically detects female hormones and steroid hormones from urine at the time of urination, so that daily work can be performed without complicated work for detecting hormones. It is easy to use and can continuously manage health.

[Brief description of the drawings]

FIG. 1 is a configuration diagram of a health management device according to an embodiment of the present invention.

FIG. 2 is a diagram showing changes in female hormones (ovarian hormone, luteal hormone) during the ovarian cycle.

[Explanation of symbols]

 DESCRIPTION OF SYMBOLS 1 Toilet seat apparatus 2 Toilet 3 Hormone detection part 4 Urine sensor 5 Female hormone detection means 6 Steroid hormone detection means 7 Arithmetic circuit 8 Hormone signal storage means 9 Ovarian cycle calculation means 10 Cancer risk estimation calculation means 11 Cancer risk risk Storage means 12 Personal information input means 13 Operation display means

──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-61-141900 (JP, A) JP-A-3-215745 (JP, A) JP-A-56-46894 (JP, A) JP-A-60-141 120255 (JP, A) JP-A-56-95119 (JP, A) JP-A-54-119993 (JP, A) JP-A-3-96537 (JP, A) JP-A-5-306539 (JP, A) JP-A-4-225161 (JP, A) JP-A-3-80363 (JP, U) JP-A-3-36609 (JP, U) (58) Fields investigated (Int. Cl. ⁷ , DB name) G01N 33/74 G01N 33/50 A61B 10/00

Claims (2)

(57) [Claims] 1. A female hormone detecting means for detecting a female hormone, a steroid hormone detecting means for detecting a steroid hormone, and a hormone signal storage for storing output signals of the female hormone detecting means and the steroid hormone detecting means in time series. Means, an ovarian cycle calculating means for calculating an ovarian cycle from a change in the amount of female hormone stored in the hormone signal storage means, and a risk of developing a female-specific cancer from the amounts of female hormone and steroid hormone at a predetermined time of the ovarian cycle. Cancer onset risk rate estimating means for estimating and calculating the cancer occurrence risk rate storing means for storing the output results of the cancer onset risk rate estimating means in time series, and cancer onset risk rate storing means Health management system provided with a display means for displaying the stored contents of the. 2. The health management system according to claim 1, wherein the hormone detecting means is configured to detect female hormones and steroid hormones based on an output of a urine sensor provided in the toilet.